Interesting slide shows about the world
Slideshow World by [ArcaMax](?ezine=782&r=XmZRwqdCss4pPuBidmGv3bgG_TCZvmVccfdprM09NuNDOjMyNzAwODM2NDpKOjIwOTQ3MjE6TDo3ODI6Ujo3MTY0NDE6Vjo0Ng) Sponsor [firstName]... What's Your Employment Situation? Are you... Under Employed? Unemployed? Over Employed? [Act now to participate]( in National Consumer Center's $1000 March Check Promotion. Pretty simple - All you do is answer a few questions about your employment situation - Takes less than 2 minutes. [Then, get a $1000 Check to help make ends meet]( details apply. So, to get started, [please follow this link.]( [How the availability of COVID-19 treatments has changed throughout the pandemic]( Betsy Ladyzhets [ How the availability of COVID-19 treatments has changed throughout
the pandemic ]( [See full slideshow »]( At the beginning of the COVID-19 pandemic in March 2020, doctors had limited knowledge of how to respond to this new disease. Physicians in hard-hit regions across the world had to learn as they treated the first wave of patients, relying on ventilators and high-flow oxygen treatments, as well as early drugs such as hydroxychloroquine and remdesivir to reduce patients’ risk of dying. Years later, we have since seen several vaccines prove highly effective in preventing severe disease. The Pfizer/BioNTech, Moderna, and Johnson & Johnson vaccines were all developed in record time, building upon past research into coronavirus vaccines and genetic technology. In December 2021, unvaccinated adults in the U.S. were 2.4 times more likely to test positive for COVID-19 than fully vaccinated adults and were 14 times as likely to die of the disease, according to the Centers for Disease Control and Prevention. The likelihood of unvaccinated infection rose to 2.6 times as recently as January 2022. At the same time, pharmaceutical companies have developed a variety of drugs that may alleviate COVID-19 symptoms in those who test positive. Monoclonal antibody treatments provide a boost to the immune system, as patients receive infusions of lab-made proteins designed to fight off the coronavirus. In December 2021, the U.S. Food and Drug Administration provided emergency authorization to an antiviral pill treatment that reduces the risk of COVID-19 hospitalization and death. Both the monoclonal antibodies and pills are most effective when patients receive treatment soon after their COVID-19 symptoms begin. Relative to the fact that this is a novel disease never before known to medical science, progress in treatment development has been remarkably swift and agile. Stacker compiled a list of milestones in the availability of COVID-19 treatments and vaccines throughout the first two years of the pandemic, using information from the Centers for Disease Control and Prevention, the U.S. Food and Drug Administration, and media reports. Visit thestacker.com for similar lists and stories. © 2022 Stacker Media, LLC; Distributed by Tribune Content Agency, LLC [Tweet It]( - [Facebook It]( Sponsor [Get Your Goodie Box](... Free Samples and a lot more... Every Month we'll send you a box of free goodies and all you do is let us know what you think. Big Companies want to know how their 'next big thing' really works for you... And Shipping is Free. No credit card required EVER! Hurry we are sending out Goodie Boxes daily... [Sign up here - Free!]( And see if you qualify for a Goodie Box! [ Politics Digests: Right, Left And Everything In Between ]
Politics Digests: Right, Left And Everything In Between Get political news, columns and editorial cartoons by subscribing below. Use the links to instantly subscribe: * [Righteous Right](
* [Proud Progressive](
* [Digest: Right, Left, Moderate](
* [Editorial Cartoons Only]( -- From the ArcaMax editors
httpss://ww2.liveintent.com/ad-choices.html
More Slideshow World from ArcaMax.com - [How wildfires have worsened in recent years](
- [How social media rebuilt advertising](
- [10 ways to build your brand on social media]( You Might Like
[Learn more about RevenueStripe...](
[Click To Unsubscribe]( | [Customer Service]( | [Privacy Policy]( | [California / Nevada Privacy Info](
11830 Canon Blvd. Ste A, Newport News, Va 23606 Copyright © 2022 ArcaMax Publishing [Facebook]( [Twitter](/ArcaMax)